|
1 Bian ML. Brief introduction of the practical guideline about preventing and curing cervical cancer by WHO(2006). Chin J Pract Gynecol Obstet, 2007, 23(7)：557-560.[卞美璐.WHO(2006年)宫颈癌综合防治实践指南简介.中国实用妇科与产科杂志，2007，23(7)：557-560.]
|
|
2 Benedef JL, Odicino F，Maisonneuve P, et al. Carcinoma of the cervix uteri. Int J Gynaecol Obstet, 2006, 95(Suppl 1):43-103.
|
|
3 Torabi M，Aquino SL, Harisinghani MG，et al. Current concepts in lymph node imaging. J Nucl Med, 2004，45(9)：1509.
|
|
4 Kamura T，Shigematsu T. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy. Acta Obstet Gynecol Scand, 1999，78(5)：452-457.
|
|
5 Cheng X，Cai SM，Li ZT，et al. Multidisciplinary therapy after radical surgery in stage I b1~Ⅱ b cervical cancer patients with positive lymph nodes. Chin J Obstet Gynecol, 2005，40(8)：539-543.[程玺，蔡树模，李子庭等.淋巴结转移的I bl~Ⅱ b期子宫颈癌患者手术后的综合治疗及预后分析.中华妇产科杂志，2005，40(8)：539-543.]
|
|
6 Wu SH, Zhang J, Li Y，et al. Analysis of prognostic factors in stage I b- Ⅱ a cervical cancer patients. Chin J Obstet Gynecol, 2007，42(2)：131-132.[吴素慧，张静，李颖等.子宫颈癌I b和Ⅱ a期患者预后相关因素的分析.中华妇产科杂志，2007，42(2)：131-132.]
|
|
7 Cao ZY ed. Chinese obstetrics and gynecology. 2th ed. Beijing：People's Medical Publishing House, 2004,2030-2089.[曹泽毅主编.中华妇产科学.第2版.北京：人民卫生出版社，2004,2030-2089.]
|
|
8 Metindir J, Bilir G. Prognostic factors affecting disease-free survival in early-stage cervical cancer patients undergoing radical hysterectomy and pelvic-paraaortic lymphadenectomy. Eur J Gynaecol Oncol，2007, 28(1)：28-32.
|
|
9 Atasii T，Aksu MF，Cetinkaya MB. Prognostic factors that affect survival after the treatment of early stage cervical carcinoma. Int Surg, 2000，85(2)：147-151.
|
|
10 Morice P，Piovesan P, Rey A, et al. Prognostic value of lymphovascular space invasion determined with hematoxylin-eosin staining in early stage cervical carcinoma：Results of a multivariate analysis. Ann Oncol, 2003，14(10)：1511-1517.
|
|
11 Takeda N, Sakuragi N，Takeda M, et al. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta Obstet Gynecol Scand, 2002, 81(12): 1144-1151.
|
|
12 Ayhan A, Al RA, Baykal C，et al. Prognostic factors in FIGO stage I B cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy. Int J Gynecol Cancer, 2004，14(2)：286-292.
|
|
13 Sakuragi N, Takeda N，Hareyama H, et al. A multivariate analysis of blood vessel and lymph vessel invasion as predictors of ovarian and lymph node metastases in patients with cervical carcinoma. Cancer, 2000，88(11)：2578-2583.
|
|
14 Hopkins MP, Peters WA, Andersen W，et al. Invasive cervical cancer treated initially by standard hysterectomy. Gynecol Oncol, 1990，36(1)：7-12.
|
|
15 Abeler VM, Holm R，Nesland JM，et al. Small cell carcinoma of the cervix. A clinicopathologic study of 26 patients. Cancer, 1994, 73(3): 672-677.
|
|
16 Takehara K，Shigemasa K. Recurrence of invasive cervical carcinoma more than 5 years after initial therapy. Obstet Gynecol, 2001，98(4): 680-684.
|
|
17 Nakanishi T，Ishikawa H，Nawa A，et al. The significance of tumor size in clinical stage I B cervical cancer：Can a cut-off figure be determined? Int J Gynecol Cancer, 2000，10:397-401.
|
|
18 Charles L. Cervical cancer. IGCS, 2006,231-247.
|
|
19 Benedet JL, Odicino F，Maisonneuve P，et al. Carcinoma of the cervix. FIGO annual report. J Epid Biostat, 2001，6(3)：5.
|
|
20 Kaur H, Silverman PM，Lyer RB, et al. Diagnosis, staging, and surveillance of cervical carcinoma. A J R, 2003，180(6)：1621.
|
|
21 Dalstein V，Riethmuller D，Pretet JL, et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions：A longitudinal French cohort study. Int J Cancer, 2003，106(3): 396-403.
|
|
22 Hsu KF, Huang SC, Hsiao JR, et al. Clinical significance of serum human Papillomavirus DNA in cervical carcinoma. Obstet Gynecol，2003，102(6)：1344-1351.
|
|
23 Cao ZY ed. A manual of diagnosing and treating common gynecologic malignant tumor. 2th ed. Beijing：People's Medical Publishing House, 2007,23-40.[曹泽毅主编.妇科常见恶性肿瘤诊治指南.第2版.北京：人民卫生出版社，2007,23-40.]
|
|
24 Hoffman MS，Cardosi RJ，Roberts WS，et al. Accuracy of pelvic examination in assessment of patients with operable cervical cancer. Am J Obstet Gynecol, 2004, 190：986-993.
|
|
25 Baltzer J，Kopcke W，Lohe KJ，et al. Surgic treatment of cervical cancer：Treatment results and data on the postoperative course over a minimum of 5 years following uniform surgery and standardized histological examination of the histologic material of 1 092 patients at 4 university gynecology clinics(German). Geburt Shilfe Frauenheilkd，1984，44: 279-285.
|
|
26 Oellinger JJ, Blohmer JU，Michniewicz K，et al. Pre-operative staging of cervical cancer：Comparison of magnetic resonance imaging(MRI)and computed tomography(CT)with histologic results. Zentralblatt Fur Gynakologie，2000，122(2):82-91.
|
|
27 Sheu MH, Chang CY, Wang JH, et al. Preoperative staging of cervical carcinoma with MR imaging：A reappraisal of diagnostic accuracy and pitfalls. Eur Radiol, 2001, 11(9)：1828-1833.
|
|
28 Park W，Park YJ, Huh SJ, et al. The usefulness of MRI and PET imaging for the detection of parametrial involvement and lymph node metastasis in patients with cervical cancer. Jpn J Clin Oncol，2005，35(5)：260-264.
|
|
29 Bellomi M，Bonomo G，Landoni F，et al. Accuracy of computed tomography and magnetic resonance imaging in the detection of lymph node involvement in cervix carcinoma. Eur Radiol，2005,15(12)：2469-2474.
|
|
30 Scheidler J, Hricak H, Yu KK, et al. Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. JAMA, 1997，278(13):1096-1101.
|
|
31 Wright JD, Dehdashti F, Herzog TJ, et al. Preoperative lymph node staging of early-stage cervical carcinoma by[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography. Cancer, 2005，104(11)：2484-2491.
|